Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Fisetin

Fisetin · also known as Fisetin, Smoke tree (Cotinus coggygria) extract

Fisetin showed potential to clear senescent cells in cell studies and in some high-dose mouse models, and it can affect mTOR, autophagy and inflammation-related markers. There is no reliable evidence that typical supplement doses selectively clear senescent cells in humans.

Typical dose: Common supplement doses are 100–250 mg/day, but this range has not been established as an effective or long-term safe dose. The intermittent pulse regimen used in clinical studies (20 mg/kg body weight for 2–3 consecutive days, once a month) is a research protocol and is not suitable for routine use.
Absorption and forms: Fisetin is highly fat-soluble and poorly water-soluble, so plain powder taken by mouth is usually poorly absorbed. Liposomal and nanomicelle forms, or forms co-dissolved with sunflower lecithin, may improve absorption, but this cannot be assumed for every product. Go by the human data for the specific product.

Clinical uses and human evidence

Inflammation markers (such as CRP)

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Farsad-Naeimi A 2018 · Food Funct · RCT · n=37 — Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients

Fatigue and energy

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Hodgin 2021 · Int J Environ Res Public Health · Other human study · n=21 — A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea)

Mechanisms of action

Apoptosis-driven clearance of senescent cells (senolytic activity)

★★★☆☆Mechanism evidence: grade CPrimary target

Fisetin showed potential to clear senescent cells in some cell models and in high-dose mouse experiments, where markers of senescence fell in some fat tissues. Selective clearance of senescent cells in humans has not been confirmed. The animal doses were high and should not be extrapolated to typical supplement doses.

References (2)
  1. Yousefzadeh et al. 2018 · Aged mouse study: after 100 mg/kg orally for 5 consecutive days, senescent-cell markers fell in some fat tissues
  2. Overall assessment · Human evidence: there is no reliable evidence that typical supplement doses selectively clear senescent cells in humans

mTORC1 allosteric inhibition and macroautophagy induction

★★★☆☆Mechanism evidence: grade CSecondary target

In some animal models, fisetin changed mTOR and autophagy-related markers, and the direction of the effect varied by model. In a few cell models, autophagy was actually suppressed. Effects on autophagic flux in humans, and whether any effect depends on SIRT1, have not been confirmed.

References (2)
  1. Sattari et al. 2025 · Mouse study: after 80 mg/kg/day, mTOR and autophagy-related markers changed in the liver
  2. 2020 · Cell study: in some liver cancer cell models, autophagy was instead suppressed

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade CSecondary target

In some animal models of inflammation, fisetin can reduce p65 nuclear entry and DNA binding. A drop in pro-inflammatory SASP factors does not by itself prove that NF-κB was inhibited, and the effect on this pathway in humans after usual oral doses is not yet clear.

References (1)
  1. Goh et al. 2012 · Mouse study of allergic airway inflammation: p65 nuclear entry and DNA binding fell in lung tissue

Safety and drug interactions

People taking anticoagulants such as warfarin should be aware of a possible interaction through drug-metabolizing enzymes. Human data are limited, so consult a doctor and consider monitoring. Long-term safety data are also insufficient.
Open in the interactive app ›